These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 413153)

  • 1. The pattern of the whole body distribution of radioactive copper (67Cu, 64Cu) in Wilson's Disease and various control groups.
    Walshe JM; Potter G
    Q J Med; 1977 Oct; 46(184):445-62. PubMed ID: 413153
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies with radioactive copper (64Cu and 67Cu): abdominal scintiscans in patients with Wilson's disease.
    Osborn SB; Szaz KF; Walshe JM
    Q J Med; 1969 Oct; 38(152):467-74. PubMed ID: 5355538
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of copper metabolism in kinky hair disease (Menkes' disease) and in hepatolenticular degeneration (Wilson's disease) utilizing 67Cu and radioactivity counting in the total body and various tissues.
    Dekaban AS; O'Reilly S; Aamodt R; Rumble WF
    Trans Am Neurol Assoc; 1974; 99():106-9. PubMed ID: 4219083
    [No Abstract]   [Full Text] [Related]  

  • 4. The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
    Gibbs K; Hanka R; Walshe JM
    Q J Med; 1978 Jul; 47(187):349-64. PubMed ID: 715173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Iron and copper metabolism in hemochromatosis and Wilson's disease. Studies on relatives of patients].
    Petera V; Lahn V; Virt S; Voleníková L; Kohout J
    Z Gesamte Inn Med; 1969 May; 24(10):315-9. PubMed ID: 5807434
    [No Abstract]   [Full Text] [Related]  

  • 6. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metabolism in Wilson's disease. Whole body counting of 64Cu].
    Terao T; Nakao K; Ogihara K; Mozai T; Nagai T
    Igaku To Seibutsugaku; 1967 Jun; 74(6):304-8. PubMed ID: 5624888
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolution of the hepatic lesion in Wilson's disease (hepatolenticular degeneration).
    Sternlieb I
    Prog Liver Dis; 1972; 4():511-25. PubMed ID: 4569009
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members.
    Merli M; Patriarca M; Loudianos G; Valente C; Riggio O; De Felice G; Petrucci F; Caroli S; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body retention of injected 67Cu in patients with homozygous or heterozygous Wilson's disease and in normal subjects. Comparison of whole-body counting systems.
    Tauxe WN; Willvonseder R; Goldstein NP
    Mayo Clin Proc; 1974 Jun; 49(6):382-6. PubMed ID: 4209105
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term body retention of radiocopper (67Cu) and the diagnosis of Wilson's disease.
    Willvonseder R; Goldstein NP; Tauxe WN
    Mayo Clin Proc; 1974 Jun; 49(6):387-93. PubMed ID: 4835809
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies with radioactive copper (64Cu and 67Cu) in relation to the natural history of Wilson's disease.
    Osborn SB; Walshe JM
    Lancet; 1967 Feb; 1(7486):346-50. PubMed ID: 4163882
    [No Abstract]   [Full Text] [Related]  

  • 13. [Kinetics of radioactive copper in Wilson's disease].
    Willvonseder R; Goldstein NP; Tauxe WN
    Wien Z Inn Med; 1973; 54(5):226-33. PubMed ID: 4790777
    [No Abstract]   [Full Text] [Related]  

  • 14. Observations on copper metabolism in Wilson's disease.
    Czlonkowska A; Galewicz A; Rodo M; Wehr H
    Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of the heterozygote of Wilson's disease.
    O'Reilly S; Weber P; Pollycove M; Shipley L
    J Nucl Med; 1969 Mar; 10(3):143-4. PubMed ID: 5785018
    [No Abstract]   [Full Text] [Related]  

  • 16. [Radioactive copper in the diagnosis of Wilson's disease].
    Czlonkowska A; Wehr H; Galewicz A; Harmak E; Rodo M; Wald I
    Pol Tyg Lek; 1973 May; 28(17):597-9. PubMed ID: 4712325
    [No Abstract]   [Full Text] [Related]  

  • 17. [Wilson's disease in Switzerland. Clinical, genetic and biochemical studies].
    Tschumi A; Colombo JP; Moser H
    Schweiz Med Wochenschr; 1973 Jan; 103(3):89-95. PubMed ID: 4683518
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of Wilson's disease with an atypical clinical course].
    Michałowska-Kurowska M; Czajka M; Kadylak B
    Pol Merkur Lekarski; 1996 Sep; 1(3):204-6. PubMed ID: 9139791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies with radiocopper (64Cu) in Wilson's disease: dynamics of copper transport.
    Osborn SB; Walshe JM
    Clin Sci; 1965 Dec; 29(3):575-81. PubMed ID: 5848709
    [No Abstract]   [Full Text] [Related]  

  • 20. Investigations by the use of radioactive copper (64Cu) in chronic liver diseases.
    Wysocki K; Owczarek L; Górski S; Kurnatowska A
    Pol Med J; 1969; 8(1):43-9. PubMed ID: 5782169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.